Explore the Future of Biomanufacturing

Welcome to my blog! I'm James, a strategic advisor and coach with over 20 years of experience in biotech and executive leadership. I've built high-performing teams and led groundbreaking research in stem cell metabolism, regenerative medicine, and cultured meat. As a passionate advocate for biomanufacturing's world-changing potential, I'm excited to share my knowledge and ideas with you.

What You’ll Discover Here

🔬 Latest Innovations: Explore cutting-edge advancements in biomanufacturing, cultivated meat, and cellular agriculture.
🚀 Founder's Corner: Access valuable tools and insights developed for my coaching program, tailored specifically for technical founders.
🎙️ Industry Voices: Every two weeks, enjoy an in-depth interview with a founder, investor, or operator in the biomanufacturing space.

🍖The B2B value chain for cultured meat
Cultivated Meat James Ryall Cultivated Meat James Ryall

🍖The B2B value chain for cultured meat

I’ve created an end-to-end value chain for B2B companies that not only focuses on cultured meat but shows how the value provided by these companies can be applied to virtually any bio-manufactured product. What’s even more exciting is that less than half of these companies existed five years ago 🔍.

Read More
🎙️ Microfluidics for large scale cell harvesting?

🎙️ Microfluidics for large scale cell harvesting?

Traditionally, centrifugation, whether continuous or batch, has been the go-to solution. But, as we aim for higher volumes, striking a balance between efficiency, speed, and cell integrity becomes a significant challenge 🔄. This is where innovative approaches like microfluidics might come into play.

Read More
🍖Class-specific growth factors for cultured seafood?

🍖Class-specific growth factors for cultured seafood?

In an industry where cost reduction and yield maximization are critical for commercial viability 💰📈, the need for species- or class-specific growth factors will likely become evident. This need is particularly acute in the context of crustacean cell culture, which generally shows poor responsiveness to mammalian serum. 🦐

Read More
🚀Unlocking Potential: Exosomes & Cultured Meat Synergy 🌱🔬

🚀Unlocking Potential: Exosomes & Cultured Meat Synergy 🌱🔬

The commercial scale production of cultured meat will lead to an intriguing by-product: spent media. This medium, though (somewhat) nutrient-depleted and filled with waste, harbors a treasure trove of extracellular vesicles known as exosomes. Packed with proteins, lipids, and RNA, these tiny powerhouses have vast potential in a myriad of applications, including the therapeutic and broader biomanufacturing spaces.

Read More
🍖From One-at-a-Time to Automation and Data Modelling in Media Optimisation 🔄

🍖From One-at-a-Time to Automation and Data Modelling in Media Optimisation 🔄

With the cell and gene therapy industry shifting more towards Industry 4.0, focusing on automation, large-scale data analysis and modelling, and AI, I imagine we're going to see an increasing number of third-party solutions to the media design problem. This should have the flow-on effects of increasing yield and reducing costs - for therapies, for food and for any product developed using biomanufacturing 🌐.

Read More
🚀Navigating the "Holy Trinity" of Biomanufacturing

🚀Navigating the "Holy Trinity" of Biomanufacturing

In my four-year journey through the biomanufacturing landscape, (primarily focussed on applications for cultured meat), a recurring theme has emerged: the success of any biomanufacturing process hinges on a harmonious blend of the right cell line 🧬, the perfect media formulation 🧪, and a finely tuned bioprocess 🔄.

Read More